Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Public ClinicalTrials.gov record NCT03526549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Open-Label, Long-Term Study to Evaluate the Safety and Temporal Pattern of Response of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3b, Open-Label Extension Study to evaluate safety and how long response of EN3835 (Collagenase Clostridium Histolyticum \[CCH\]-aaes) lasts in the treatment of Cellulite.
Study identification
- NCT ID
- NCT03526549
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 483 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2018 (Actual)
- Primary completion
- Oct 8, 2021 (Actual)
- Completion
- Oct 8, 2021 (Actual)
- Last update posted
- Sep 8, 2023
2018 – 2021
United States locations
- U.S. sites
- 42
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #3 | Glendale | Arizona | 85308 | — |
| Endo Clinical Trial Site #11 | Scottsdale | Arizona | 85258 | — |
| Endo Clinical Trial Site #41 | North Little Rock | Arkansas | 72116 | — |
| Endo Clinical Trial Site #14 | Encinitas | California | 92024 | — |
| Endo Clinical Trial Site #9 | Long Beach | California | 90806 | — |
| Endo Clinical Trial Site #35 | Murrieta | California | 92562 | — |
| Endo Clinical Trial Site #42 | Newport Beach | California | 92663 | — |
| Endo Clinical Trial Site #17 | Oceanside | California | 92056 | — |
| Endo Clinical Trial Site #39 | San Diego | California | 92121 | — |
| Endo Clinical Trial Site #23 | Greenwood Village | Colorado | 80111 | — |
| Endo Clinical Trial Site #38 | Boca Raton | Florida | 33486 | — |
| Endo Clinical Trial Site #8 | Coral Gables | Florida | 33146 | — |
| Endo Clinical Trial Site #40 | Largo | Florida | 33770 | — |
| Endo Clinical Trial Site #27 | Miami | Florida | 33137 | — |
| Endo Clinical Trial Site #36 | Miami | Florida | 33185 | — |
| Endo Clinical Trial Site #20 | Snellville | Georgia | 30078 | — |
| Endo Clinical Trial Site #19 | Meridian | Idaho | 83642 | — |
| Endo Clinical Trial Site #34 | Chicago | Illinois | 60654 | — |
| Endo Clinical Trial Site #30 | Indianapolis | Indiana | 46260 | — |
| Endo Clinical Trial Site #16 | Metairie | Louisiana | 70006 | — |
| Endo Clinical Trial Site #10 | New Orleans | Louisiana | 70115 | — |
| Endo Clinical Trial Site #25 | New Orleans | Louisiana | 70124 | — |
| Endo Clinical Trial Site #33 | Quincy | Massachusetts | 02169 | — |
| Endo Clinical Trial Site #18 | Washington | Missouri | 63090 | — |
| Endo Clinical Trial Site #4 | Omaha | Nebraska | 68144 | — |
| Endo Clinical Trial Site #24 | Mount Kisco | New York | 10549 | — |
| Endo Clinical Trial Site #32 | New York | New York | 10016 | — |
| Endo Clinical Trial Site #12 | New York | New York | 10022 | — |
| Endo Clinical Trial Site #15 | New York | New York | 10065 | — |
| Endo Clinical Trial Site #29 | New York | New York | 10075 | — |
| Endo Clinical Trial Site #26 | Cincinnati | Ohio | 45236 | — |
| Endo Clinical Trial Site #5 | Nashville | Tennessee | 37215 | — |
| Endo Clinical Trial Site #22 | Austin | Texas | 78759 | — |
| Endo Clinical Trial Site #6 | Beaumont | Texas | 77701 | — |
| Endo Clinical Trial Site #13 | Houston | Texas | 77056 | — |
| Endo Clinical Trial Site #7 | Houston | Texas | 77494 | — |
| Endo Clinical Trial Site #28 | Pflugerville | Texas | 78660 | — |
| Endo Clinical Trial Site #21 | San Antonio | Texas | 78229 | — |
| Endo Clinical Trial Site #37 | Sugar Land | Texas | 77497 | — |
| Endo Clinical Trial Site #31 | Salt Lake City | Utah | 84101 | — |
| Endo Clinical Trial Site #1 | Charlottesville | Virginia | 22911 | — |
| Endo Clinical Trial Site #2 | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03526549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2023 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03526549 live on ClinicalTrials.gov.